Human gene therapy: A cure for all ills?

This briefing examines the case for gene therapy and considers the safety, social and ethical concerns. […]

A Critique of the Biosafety Clearing House

This analysis addresses concerns about the Biosafety Clearing House established under the Cartegena Protocol on Biosafety as it currently exists in “pilot” form. […]

A-maize-ing Chardon LL fiasco

In the UK, regulatory shortcomings surrounding Chardon LL have come to light following renewed disclosure that its safety tests were fundamentally flawed. […]

Trilateral Agreement Undermines Biosafety Protocol

The Human Genome Map, the Death of Genetic Determinism and Beyond

Dr Mae-Wan Ho reports on the publication of the human genome map in 2001 and assesses its implications. The findings on the nature of genes is crucial in understanding why genetic engineering is flawed and why it gives rise to serious biosafety concerns. […]

BMA Calls for Caution, Urges More Research

Human Genome -The Biggest Sellout in Human History

This report by Dr Mae-Wan Ho was written before the final publication of the complete human genome map in 2001. […]

The Killing Fields: Terminator Crops at Large

Three scientists, Drs. Mae-Wan Ho, Joe Cummins and Jeremy Bartlett describes what “terminator technology” involves, the scientific implications and its threats to biodiversity and human health. […]

Killer virus sparking biotech fears

In 2001, a deadly new virus was created during a genetic engineering experiment has set off warning bells that the use of the technology should be very carefully monitored and regulated. […]

Liability and Redress: The Starlink Case

Gurdial Singh Nijar presents the StarLink case, which involved the contamination of GE corn not approved for humans in the food chain, as an example to examine issues related to liability and redress for harm arising from GMOs. […]